OakChart

Basel Medical Group Ltd

BMGLHealthcare·Medical Care Facilities·Singapore·Nano·NASD·Nov 11 • 9:52 AM ET

0.7600-1.1700 (-60.62%)
2026-11-11 15:53 CET
Market cap
26.21 USD m
Revenue, TTM
12.81 USD m
Net income, TTM
-0.59 USD m
Free cash flow, TTM
-0.69 USD m
EPS diluted, TTM
-0.37
P/E
-
Compare

Price

BMGL against its 20, 50 and 200-day averages
2050200
0.005.0010.0015.0016.0M31.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BMGLclose 0.7620-day 4.3550-day 4.25200-day 6.390.76

96.2% under 19.92 on 24 Oct 2025. Last 15 sessions, 693.4% high to low

Profile

BMGL
52-week range, 0% of the way up
1.5318.48

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Employees74
IPOFeb 26, 2025
Beta0.35
ATR, 14d0.67
Rel volume13.06
Short float1.74%
Insider own54.32%
Inst own0.00%

Snapshot

6 groups

Valuation

Index-
Market Cap10.32M
Enterprise Value16.20M
Income-0.59M
Sales12.81M
Book/sh2.47
Cash/sh0.03
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees74
IPOFeb 26, 2025

Ratios

P/E-
Forward P/E-
PEG-
P/S0.81
P/B0.31
P/C25.17
P/FCF-
EV/EBITDA-
EV/Sales1.26
Quick Ratio1.20
Current Ratio1.23
Debt/Eq1.71
LT Debt/Eq0.67
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.37
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y21.68% 13.06%
EPS Y/Y TTM92.79%
Sales Y/Y TTM49.87%
EPS Q/Q89.89%
Sales Q/Q34.74%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own54.32%
Insider Trans0.00%
Inst Own0.00%
Inst Trans-5.56%
ROA-4.13%
ROE-14.37%
ROIC-8.99%
Gross Margin-0.96%
Oper. Margin-33.10%
Profit Margin-4.59%
SMA20-82.54%
SMA50-82.11%
SMA200-88.10%
Trades-

Technical

Shs Outstand13.58M
Shs Float6.20M
Short Float1.74%
Short Ratio0.08
Short Interest0.11M
52W High18.48 -95.89%
52W Low1.53 -50.33%
Volatility57.58% 18.43%
ATR (14)0.67
RSI (14)19.42
Beta0.35
Rel Volume13.06
Avg Volume1.30M
Volume1,752,148

Performance

Perf Week-85.36%
Perf Month-80.26%
Perf Quarter-83.55%
Perf Half Y-91.24%
Perf YTD-87.07%
Perf Year-95.67%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom-
Target Price-
Prev Close1.93
Price0.76
Change %-60.62%

Peers

Mkt cap
TickerCompanyMkt cap
SGRYSurgery Partners Inc3.48B
PARKPark Dental Partners Inc96.39M
AUNAAuna SA339.72M
CCMConcord Medical Services ADR10.38M
JYNTJoint Corp92.68M
USPHU.S. Physical Therapy Inc1.49B
AIRSAirsculpt Technologies Inc58.22M
NIVFNewGenIvf Group Ltd0.35M
SYSo-Young International Inc ADR176.82M
MNDRMobile health Network Solutions1.11M

News

latest 14 of 42
  • Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering (GlobeNewswire)
  • Basel Medical Group Ltd (BMGL) Prices Registered Direct Offering (GlobeNewswire) +9.76%
  • BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
  • Why Did BMGL Stock Slump 18% Today? (Stocktwits) -8.01%
  • BMGL to Effect Reverse Share Split on June 22, 2026 (GlobeNewswire)
  • Loading…
  • Compliance With Nasdaq Periodic Filing Requirement (GlobeNewswire) -7.26%
  • Receipt of Delinquency Notification from Nasdaq (GlobeNewswire)
  • Receipt of Delinquency Notification from Nasdaq (GlobeNewswire)
  • Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset (GlobeNewswire) -14.29%
  • Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising (GlobeNewswire) -12.62%
  • Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility (GlobeNewswire)
  • Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement (GlobeNewswire) -36.90%
  • Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities (GlobeNewswire) -6.57%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual1.0740.9651.135-5.128-0.368
Period20222023202420252026
EPS, quarterly
Period
Sales, annual7.8387.1097.4538.54412.806
Period20222023202420252026
Sales, quarterly
Period
Shares, annual1.3541.3541.3541.5651.582
Period20222023202420252026
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY
Total Revenue12.8112.818.547.457.117.84
Cost of Goods Sold Incl. D&A12.9312.947.374.674.504.75
Gross Profit-0.12-0.131.172.792.613.09
Selling, General and Administrative Excl. Other4.124.112.871.171.171.50
Other Operating Expense0.000.000.000.000.000.00
Operating Income-4.24-4.24-1.701.611.431.58
Interest Expense0.360.360.150.130.170.24
Unusual Expense-1.51-1.517.810.000.000.00
Net Income Before Taxes-0.98-0.97-8.341.781.561.75
Income Taxes0.140.14-0.320.250.260.30
Consolidated Net Income-1.12-1.11-8.031.541.311.45
Net Income From Continuing Operations-0.59-0.58-8.031.541.311.45
Net Income-0.59-0.58-8.031.541.311.45
EPS (Recurring)-1.04-1.04-1.641.140.961.07
EPS (Basic, Before Extraordinaries)-0.37-0.37-5.131.140.961.07
EPS (Diluted)-0.37-0.37-5.131.140.961.07
EBITDA-1.21-1.21-0.812.011.842.01
Non-Operating Income (Expense)2.112.111.320.300.300.41
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense-0.19----
Price To Earnings Ratio--1,002.82985.92--
Price To Sales Ratio0.860.863.91---
Gross Margin-0.96-1.0113.7137.3736.7039.37
Operating Margin-33.10-33.11-19.9021.6420.1820.20
Net Margin-4.59-4.55-93.9620.6218.3818.56
Shares Outstanding1.581.581.571.351.351.35
Market Capitalization26.2126.21401.26394.50--

Income statement, quarterly

Currency USD, millions
Metric2026S22026S12025S22025S12024S22024S12023S22023S1
Total Revenue6.406.414.753.803.683.773.493.62
Cost of Goods Sold Incl. D&A5.767.174.243.132.642.121.762.61
Gross Profit0.64-0.760.510.671.041.651.731.01
Selling, General and Administrative Excl. Other2.621.501.771.100.820.260.790.51
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.97-2.26-1.27-0.430.221.390.940.50
Interest Expense0.190.170.080.070.060.070.080.10
Unusual Expense0.00-1.517.820.000.000.000.000.00
Net Income Before Taxes-1.240.26-8.11-0.240.351.441.150.43
Income Taxes0.000.14-0.320.00-0.210.450.26-0.00
Consolidated Net Income-1.240.12-7.80-0.240.550.980.880.43
Net Income From Continuing Operations-0.800.21-7.79-0.240.550.980.880.43
Net Income-0.800.21-7.79-0.240.550.980.880.43
EPS (Recurring)-0.50-0.54-1.48-0.150.410.730.650.32
EPS (Basic, Before Extraordinaries)-0.500.13-4.98-0.150.410.730.650.32
EPS (Diluted)-0.500.13-4.98-0.150.410.730.650.32
EBITDA-0.54-0.67-0.64-0.170.421.581.120.73
Non-Operating Income (Expense)0.921.191.050.270.180.120.280.02
Price To Earnings Ratio--1,002.82985.92----
Price To Sales Ratio0.860.833.91-----
Gross Margin10.03-11.9310.6417.5328.3243.8349.6627.84
Operating Margin-30.86-35.33-26.67-11.466.1036.8027.0213.84
Net Margin-12.443.26-164.16-6.3015.0426.0725.2911.98
Shares Outstanding1.581.571.571.561.351.351.351.35
Market Capitalization26.21110.46401.26394.50----

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY
Cash & Short Term Investments0.412.391.440.901.12
Short Term Receivables8.647.309.259.9210.05
Inventories0.180.380.050.070.05
Other Current Assets0.120.340.020.030.04
Total Current Assets9.3510.4110.7610.9211.26
Net Property, Plant & Equipment4.334.190.040.430.85
Total Investments and Advances0.000.000.000.000.00
Intangible Assets0.000.000.000.000.00
Deferred Tax Assets0.050.040.060.020.00
Other Assets0.030.021.170.000.00
Total Assets13.7514.6712.0311.3612.11
Short Term Debt Incl. Current Port. of LT Debt4.071.672.002.803.02
Accounts Payable1.591.610.611.080.78
Income Tax Payable0.000.000.330.350.28
Other Current Liabilities1.964.702.350.551.09
Total Current Liabilities7.627.985.294.785.17
Long Term Debt2.622.321.172.534.28
Provision for Risks Charges0.000.000.000.000.00
Deferred Tax Liabilities-0.10---
Other Liabilities0.000.000.000.000.00
Total Liabilities10.2510.406.457.319.44
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity3.914.275.584.062.66
Total Shareholders Equity3.914.275.584.062.66
Accumulated Minority Interest-0.400.000.000.000.00
Total Equity3.514.275.584.062.66
Total Liabilities & Stockholders Equity13.7514.6712.0311.3612.11
Book Value Per Share2.472.734.123.001.97
Tangible Book Value Per Share2.472.734.123.001.97
Full-Time Employees747032--
Price to Book Ratio0.7875.2473.97--
Return on Assets-4.10-60.1313.1411.13-
Return on Equity-14.25-163.0531.9038.90-
Return on Invested Capital-8.92-121.8422.7819.8420.97
Quick Ratio1.201.262.032.272.17
Current Ratio1.231.312.042.282.18

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY
Net Income-0.98-0.97-8.341.781.561.75
Depreciation3.053.030.890.390.410.42
Other Funds (Non Cash)0.530.538.14-0.31-0.28-0.18
Funds from Operations2.602.590.691.861.691.99
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.09-3.08-3.74-0.000.210.06
Cash from Operating Activities-0.49-0.49-3.051.861.912.05
Capital Expenditures-0.19-0.19-0.42-0.01-0.00-0.07
Net Assets From Acquisitions0.000.00-7.800.000.000.00
Sale of Fixed Assets and Businesses0.110.110.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.09-0.09-8.22-0.01-0.00-0.07
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock0.000.007.360.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.007.360.000.000.00
Proceedsfrom Stock Options0.000.007.360.000.000.00
Issuance or Reduction of Debt, Net2.022.01-3.22-1.75-1.70-1.11
Change in Long Term Debt-0.000.00---
Issuance of Long Term Debt-0.000.00---
Reduction of Long Term Debt-0.000.00---
Net Financing Active Other Cash Flow-1.16-1.159.300.860.00-7.99
Other Financing Activities Uses-1.16-1.15-0.08-1.18-0.44-7.99
Cash from Financing Activities-1.39-1.3812.45-1.31-2.15-9.50
Exchange Rate Effect0.000.00-0.35---
Net Change in Cash-1.97-1.960.830.54-0.25-7.51
Free Cash Flow-0.69-0.68-3.471.851.901.99
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026S22026S12025S22025S12024S22024S1
Cash & Short Term Investments0.411.042.395.461.440.72
Short Term Receivables8.649.537.303.549.2510.55
Inventories0.180.260.380.070.050.08
Other Current Assets0.120.170.340.140.020.04
Total Current Assets9.3511.0010.419.2110.7611.39
Net Property, Plant & Equipment4.334.594.190.290.040.24
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Deferred Tax Assets0.050.040.040.060.060.02
Other Assets0.030.030.021.391.170.99
Total Assets13.7515.6514.6710.9512.0312.64
Short Term Debt Incl. Current Port. of LT Debt4.072.981.673.562.002.45
Accounts Payable1.591.141.610.860.610.73
Income Tax Payable0.00-0.000.160.330.61
Other Current Liabilities1.961.734.701.042.351.79
Total Current Liabilities7.625.857.985.625.295.58
Long Term Debt2.624.702.320.001.171.90
Deferred Tax Liabilities-0.030.10---
Other Liabilities0.000.000.000.000.000.00
Total Liabilities10.2510.5810.405.626.457.48
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3.914.884.275.325.585.17
Total Shareholders Equity3.914.884.275.325.585.17
Accumulated Minority Interest-0.400.190.000.000.000.00
Total Equity3.515.074.275.325.585.17
Total Liabilities & Stockholders Equity13.7515.6514.6710.9512.0312.64
Book Value Per Share2.473.122.733.414.123.82
Tangible Book Value Per Share2.473.122.733.414.123.82
Price to Book Ratio0.7828.9475.2473.97--
Return on Assets-4.13-57.05-60.182.6713.13-
Return on Equity-14.37-148.66-163.186.0031.90-
Return on Invested Capital-12.192.18-118.31-4.498.2113.91
Quick Ratio1.201.841.261.632.032.03
Current Ratio1.231.881.311.642.042.04

Cash flow, quarterly

Currency USD, millions
Metric2026S22026S12025S22025S12024S22024S1
Net Income-1.240.26-8.11-0.240.351.44
Depreciation1.451.590.630.270.200.20
Other Funds (Non Cash)0.55-0.028.30-0.150.02-0.33
Funds from Operations0.761.840.81-0.120.561.30
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.01-3.11-1.05-2.691.19-1.20
Cash from Operating Activities0.78-1.27-0.24-2.821.760.11
Capital Expenditures-0.10-0.10-0.41-0.01-0.00-0.01
Net Assets From Acquisitions0.00-0.00-7.810.000.000.00
Sale of Fixed Assets and Businesses-0.160.270.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.260.17-8.22-0.01-0.00-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.007.370.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.007.370.000.000.00
Proceedsfrom Stock Options0.000.007.370.000.000.00
Issuance or Reduction of Debt, Net3.780.46-2.40-0.82-0.86-0.89
Net Financing Active Other Cash Flow-1.480.321.268.050.070.79
Other Financing Activities Uses-1.16-0.000.14-0.23-1.12-0.06
Cash from Financing Activities-0.83-0.565.486.98-1.01-0.30
Exchange Rate Effect-0.330.33-0.34-0.01--
Net Change in Cash-0.65-1.32-3.324.140.75-0.20
Free Cash Flow0.68-1.36-0.64-2.831.760.10

Revenue breakdown

Services-Offices & Clinics of Doctors of Medicine2025: 8.54M 2026: 12.81M
Singapore2025: 8.54M 2026: 12.81M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.74%0.1M6.2M907.68K
2026-10-150.37%0.0M3.5M639.67K
2026-09-301.57%0.0M0.7M578.63K
2026-09-1531.92%0.2M0.5M579.70K
2026-08-311.58%0.0M0.5M68.18K
2026-08-142.20%0.0M0.5M63.48K
2026-07-313.13%0.0M0.5M61.53K
2026-07-156.51%0.0M0.5M61.35K
2026-06-302.53%0.0M0.5M49.29K
2026-06-150.44%0.0M6.0M47.31K
2026-05-290.28%0.0M0.5M1.99K
2026-05-150.41%0.0M0.5M2.02K
2026-04-301.83%0.0M0.5M2.40K
2026-04-151.85%0.0M0.5M2.67K
2026-03-311.87%0.0M0.5M3.37K
2026-03-131.89%0.0M0.5M3.88K
2026-02-271.85%0.0M0.5M6.74K
2026-02-131.97%0.0M0.5M7.11K
2026-01-302.19%0.0M0.5M7.03K
2026-01-152.28%0.0M0.5M7.33K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-3020-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2026-06-30SEC
2026-10-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-29SEC
2026-10-213Initial statement of beneficial ownership of securities2026-09-02SEC
2026-10-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-13SEC
2026-10-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-09SEC
2026-10-08424B4SEC
2026-10-013Initial statement of beneficial ownership of securities2026-09-02SEC
2026-09-29EFFECTEffectiveness filing by commission orderSEC
2026-09-23F-1/ASEC
2026-09-17F-1Registration statement for certain foreign private issuersSEC
2026-09-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-02SEC
2026-08-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-10SEC
2026-07-31DRSSEC
2026-07-223Initial statement of beneficial ownership of securities2026-06-05SEC
2026-07-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-10SEC
2026-06-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-31SEC
2026-06-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-10SEC
2026-06-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-05SEC
2026-04-213Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-153Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-143Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-143Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-143Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-143Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-30SEC
2026-03-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-24SEC
2026-03-1320-F/A2025-06-30SEC
2026-03-043Initial statement of beneficial ownership of securities2025-02-18SEC
2026-01-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-23SEC
2026-01-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-21SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
UBS Group AG0.00%
Caitong International Asset Management Co., Ltd0.00%
Coston, McIsaac & Partners0.00%
Polaris Financial Partners0.00%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.04%

OakChart. BMGL. Cached 15 minutes.

Some panels did not load: ratings, insider.